Vivid Microscopy Tech Detects Stages of Cardiac Microvascular Disease, Study Shows
Vivid Microscopy's high content screening probe tech was successful in a study on coronary microvascular disease in post-menopausal women.
Vivid Microscopy's high content screening probe tech was successful in a study on coronary microvascular disease in post-menopausal women.
The U.S. CDC states that antibiotic resistant infections are responsible for killing over a million people worldwide every year.
Diagnostic screening for Down’s Syndrome during pregnancy was difficult until the development of an NIPT fetal fraction test.
A provider of AI-based solutions for cancer detection in pathology, is scaling their expertise in 3D digital pathology.
An artificial intelligence app designed to read COVID-19 lateral flow tests helped to reduce false results in a new trial.
New tech can capture stray ovarian cancer cells from a blood test and predict cancer in those who have a lesion or cyst in the pelvic region.
T2 Biosystems plans to commercialize, a diagnostic test for early Lyme disease, with a goal of releasing it in the U.S. as an LDT in 2023.
Genetic testing can diagnose cardiomyopathy in children and help detect who will have heart failure and require a transplant.
Researchers have evidence that higher levels of circulating cell-free genomic DNA in the blood may signal early signs of dementia.
Children who were infected with COVID show a substantially higher risk of developing type 1 diabetes (T1D), according to a new study.
Research shows that removing a race modifier from a formula used to diagnose kidney disease may lead to equitable care for Black patients.
Natera showcased its Prospera Lung donor-derived cell-free DNA test for assessing rejection and allograft injury in lung transplant patients.
A simple test that can be a beacon for improved patient outcomes, shorter lengths-of-stays, and reduced rates of antibiotic prescription and antibiotic resistance1-6